secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0000885725-26-000036
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific stockholders approve charter amendments and ESPP share increase at 2026 annual meeting
--------------------------------------------------------------------------------

- Approved removal of supermajority voting provisions and officer exculpation under Delaware law.
- All 10 director nominees elected with majority votes; no contested seats.
- Ratified Ernst & Young as independent auditor for 2026 fiscal year.
- Approved amendment to Employee Stock Purchase Plan to increase reserved shares.
- Stockholders did not approve proposals to allow 25% shareholders to call special meetings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572526000036/0000885725-26-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572526000036/bsx-20260430.htm
  HTML page:      https://secwatch.observer/filing/0000885725-26-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer